Answers are grounded in this paper and cite their sources.
People who inject drugs and incarcerated populations bear a disproportionate burden of hepatitis C virus (HCV) infection. Despite advances in its control, cases continue to be detected at prison entry in Barcelona (Catalonia, Spain). The aim of this study was to estimate the prevalence of HCV infection among incarcerated individuals and to identify the social determinants associated with being undiagnosed prior to imprisonment. A cross-sectional study was conducted of individuals admitted to two detention centers in Barcelona between 2021 and 2024. Sociodemographic, clinical, and penitentiary variables were collected from healthcare records and institutional databases. The proportion of active HCV infections relative to admissions was calculated descriptively. Factors associated with unawareness of infection were assessed using Poisson regression reporting PR with CI95%. The proportion of active HCV infection among screened individuals was 2.4% ( n = 281/11,830), while the proportion of active infections relative to all admissions was 2.1%. The mean age was 41.1 years; 76.9% were repeat detainees, 59.1% were foreign-born, 71.5% lacked stable housing, and 80.8% had a history of injecting drug use. Overall, 31.7% were unaware of their infection, particularly younger individuals, those foreign-born, employed persons, those without previous incarceration, and those without prior contact with the healthcare system. In multivariate analysis, factors independently associated with unawareness of HCV infection were lack of previous incarceration (PR 1.52; 95% CI: 1.15–2) and current employed (PR 1.7; 95% CI: 1.12–2.58). The prevalence of HCV at prison entry remains high, stable and concentrated among individuals in situations of greater social vulnerability. The high proportion of undiagnosed infection highlights persistent barriers to community-based detection. Tailored strategies are needed to remove barriers and improve access to the healthcare system, particularly among foreign-born individuals and socially vulnerable populations, incorporating social determinants of health, and strengthening harm reduction programmes in both community and prison settings.
No takes yet. Share an insight, caveat, or question.
Yela et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: